Application no. and date | 17734131.0 (espacenet) (Federated) (European Patent Register), 20170602 | Patent/reg. no. and date | DK/EP 3464380, 20241106 | Publication date | 20190410 | Priority no. and date | GB 201609683, 20160602, GB 201612193, 20160713, GB 201612260, 20160714 | EP pub. no. and date |
EP 3464380 20190410 | Effective date | | Applicant/owner | Immunocore Limited, 92 Park Drive Milton Park
Abingdon, Oxfordshire OX14 4RY, GB | Applicant ref. no. | PV2032DKEP | Inventor | COUGHLIN, Christina, c/o Immunocore LLC Six Tower Bridge Suite 540 181 Washington Street Conshohocken
Philadelphia Pennsylvania 19428, US | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61K 38/17 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 14/705 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) | Title | DOSERINGSSKEMA FOR GP100-SPECIFIK TCR - ANTI-CD3 SCFV-FUSIONSPROTEIN | Int. application no. | GB2017051596 | Int. publication no. | WO2017208018 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|